Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer
Despite gastric cancer being rare nowadays in Western countries, it remains one of the leading causes of cancer death worldwide. The course of the disease varies, so the individual gastric cancer patient’s prognosis is difficult to determine. The need for new biomarkers is crucial. The aim of this s...
Main Authors: | Alli Laitinen, Jaana Hagström, Harri Mustonen, Arto Kokkola, Taina Tervahartiala, Timo Sorsa, Camilla Böckelman, Caj Haglund |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2018-09-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428318799266 |
Similar Items
-
High serum MMP-14 predicts worse survival in gastric cancer.
by: Aaro Kasurinen, et al.
Published: (2018-01-01) -
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
by: Camilla Böckelman, et al.
Published: (2018-06-01) -
Podocalyxin as a Prognostic Marker in Gastric Cancer.
by: Alli Laitinen, et al.
Published: (2015-01-01) -
High PROX1 expression in gastric cancer predicts better survival.
by: Alli Laitinen, et al.
Published: (2017-01-01) -
Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.
by: Leena Arpalahti, et al.
Published: (2018-01-01)